BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11250768)

  • 1. Postmenopausal virilization, simple ovarian cyst, and hilus cell hyperplasia--is there an association?
    Braithwaite SS; Bitterman P; DeGeest K; Lebbin DR
    Endocr Pract; 2001; 7(1):40-3. PubMed ID: 11250768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virilization in a postmenopausal woman as a result of hilus cell hyperplasia associated with a simple ovarian cyst.
    Hayes FJ; Sheahan K; Rajendiran S; McKenna TJ
    Am J Obstet Gynecol; 1997 Mar; 176(3):719-20. PubMed ID: 9077639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian hilus-cell hyperplasia and high serum testosterone in a patient with postmenopausal virilization.
    Delibasi T; Erdogan MF; Serinsöz E; Kaygusuz G; Erdogan G; Sertçelik A
    Endocr Pract; 2007 Sep; 13(5):472-5. PubMed ID: 17872348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian leiomyoma with hilus cell hyperplasia that caused virilization.
    Parish JM; Lufkin EG; Lee RA; Gaffey TA
    Mayo Clin Proc; 1984 Apr; 59(4):275-7. PubMed ID: 6708605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virilization due to ovarian hyperthecosis in a postmenopausal woman.
    van Heyningen C; MacFarlane IA; Diver MJ; Muronda C; Tuffnell D
    Gynecol Endocrinol; 1988 Dec; 2(4):331-8. PubMed ID: 3232554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
    Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
    Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hyperandrogenism: the under-recognized value of inhibins.
    Shearer JL; Salmons N; Murphy DJ; Gama R
    Ann Clin Biochem; 2017 Jan; 54(1):174-177. PubMed ID: 27278937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare case of postmenopausal hyperandrogenism due to ovarian hyperthecosis and hilus cell hyperplasia.
    Johnson JE; Hussain M; Rathore A; Wolfe K
    Post Reprod Health; 2022 Mar; 28(1):51-55. PubMed ID: 35144514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal hyperandrogenism of ovarian origin. A clinicopathologic study of four cases.
    Honoré LH; Chari R; Mueller HD; Cumming DC; Scott JZ
    Gynecol Obstet Invest; 1992; 34(1):52-6. PubMed ID: 1526532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffuse stromal Leydig cell hyperplasia: a unique cause of postmenopausal hyperandrogenism and virilization.
    Taylor HC; Pillay I; Setrakian S
    Mayo Clin Proc; 2000 Mar; 75(3):288-92. PubMed ID: 10725957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
    Souto SB; Baptista PV; Braga DC; Carvalho D
    Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
    Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
    Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult virilizing ovarian tumours in postmenopausal women: problems in evaluation with reference to a case.
    Loh KC; Lo JC; Zaloudek CJ; Fitzgerald PA
    Ann Acad Med Singap; 1998 Sep; 27(5):712-6. PubMed ID: 9919347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leuprolide suppression of androgen secretion by hilus cell hyperplasia within the wall of an ovarian cyst.
    de Santiago M; Herranz L; Ordas J; Atienza M; Suarez-Mier M; Gancedo PG
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):239-42. PubMed ID: 8881459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hilus cell tumour of the ovary in a virilized, premenopausal woman. Case report and review of hyperandrogenism of ovarian origin.
    Moore A; Permezel M; Mulvany N; Pepperell RJ
    Aust N Z J Obstet Gynaecol; 1999 Feb; 39(1):75-8. PubMed ID: 10099755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent ovarian thecoma presenting as progressive hyperandrogenism: case report and review of the literature.
    Gaspari L; Paris F; Taourel P; Soyer-Gobillard MO; Kalfa N; Sultan C
    Gynecol Endocrinol; 2020 Sep; 36(9):839-842. PubMed ID: 32174224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe virilization in a postmenopausal woman.
    Conn JJ; Conway GS
    Curr Opin Obstet Gynecol; 1996 Oct; 8(5):385-9. PubMed ID: 8941440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hilus cell pathology and hirsutism.
    McLellan AR; Mowat A; Cordiner J; Beastall GH; Wallace AM; Connell JM; Davies DL
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):203-12. PubMed ID: 2112066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virilizing hilus (Leydig) cell tumor of the ovary: the challenge of an accurate preoperative diagnosis.
    Raaf JH; Bajorunas DR; Smith DH; Woodruff J
    Surgery; 1983 Dec; 94(6):951-4. PubMed ID: 6648810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.
    Meczekalski B; Szeliga A; Maciejewska-Jeske M; Podfigurna A; Cornetti P; Bala G; Adashi EY
    Gynecol Endocrinol; 2021 Aug; 37(8):677-682. PubMed ID: 33759685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.